Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
6,719,046
-
Shares change
-
+35,369
-
Total reported value, excl. options
-
$30,230,294
-
Value change
-
+$106,519
-
Number of buys
-
20
-
Number of sells
-
-16
-
Price
-
$4.5
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2014
50 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2014.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,719,046 shares
of 14,965,850 outstanding shares and own 44.9% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (2,663,520 shares), DIMENSIONAL FUND ADVISORS LP (733,379 shares), BlackRock Institutional Trust Company, N.A. (522,768 shares), KESTREL INVESTMENT MANAGEMENT CORP (352,350 shares), NEW YORK STATE COMMON RETIREMENT FUND (306,000 shares), MILLENNIUM MANAGEMENT LLC (284,144 shares), VANGUARD GROUP INC (268,832 shares), GW HENSSLER & ASSOCIATES LTD (215,904 shares), UNITED CAPITAL FINANCIAL ADVISERS, LLC (197,646 shares), and PERRITT CAPITAL MANAGEMENT INC (111,350 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.